Tabela 1.
Características basais, parâmetros laboratoriais e ecocardiográficos da população estudada
| Variable | EFT thickness ≥ 9 mm (n = 50) | EFT thickness < 9 mm (n = 40) | p value |
|---|---|---|---|
| Age, years | 61.6 ± 8.6 | 62.2 ± 6.4 | 0.71 |
| Gender, female/male | 21/29 | 19/21 | 0.60 |
| BMI, kg/m2 | 28.5 ± 2.7 | 28.1 ± 3 | 0.51 |
| Dyslipidemia, n (%) | 26(52) | 21(52) | 1.0 |
| Hypertension, n (%) | 35(70) | 28(70) | 1.0 |
| Smokers, n (%) | 15(30) | 12(30) | 1.0 |
| Glucose, mg/dL | 88.2 ± 6.4 | 87.6 ± 6.6 | 0.64 |
| TC, mg/dL | 214.5 ± 17 | 213 ± 20.3 | 0.60 |
| Triglyceride, mg/dL | 160.2 ± 18.7 | 162 ± 17.1 | 0.52 |
| LDL-C, mg/dL | 136.2 ± 9.3 | 135 ± 9.2 | 0.66 |
| HDL-C, mg/dL | 38.5 ± 2.4 | 38.8 ± 2.4 | 0.70 |
| Statins, n (%) | 13(26) | 9(22) | 0.70 |
| ACEI/ARB, n (%) | 23(65) | 14(50) | 0.20 |
| CCB, n (%) | 13(37) | 15(53) | 0.19 |
| LVEDD, mm | 46.4 ± 1.9 | 46.8 ± 2.1 | 0.41 |
| LVESD, mm | 29.4 ± 1.8 | 29.5 ± 1.9 | 0.75 |
| LA, mm | 35.2 ± 2.2 | 34.8 ± 2.2 | 0.72 |
| IVS, mm | 9.8 ± 0.9 | 10.0 ± 0.9 | 0.46 |
| PW, mm | 8.8 ± 0.6 | 8.9 ± 0.6 | 0,75 |
| LVEF, % | 56.1 ± 1.4 | 55.7 ± 1.2 | 0.20 |
| EFT thickness, mm | 10.6 ± 1.1 | 6.2 ± 1.0 | < 0.001 |
ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; BMI: Body mass index; CCB: Calcium channel blocker; EFT: Epicardial fat tissue; HDL-C: High-density lipoprotein cholesterol; IVS: Interventricular septum; LA: Left atrium; LDL-C: Low-density lipoprotein cholesterol; LVEDD: Left ventricular end-diastolic diameter; LVEF: Left ventricular ejection fraction; LVESD: Left ventricular end-systolic diameter; PW: Posterior wall; TC: Total cholesterol.